Work

Learning from our mistakes: The ‘unknown knowns’ in fragment screening

Year: 2013
Type: article
Abstract: In the past 15 years, fragment-based lead discovery (FBLD) has been adopted widely throughout academia and industry. The approach entails discovering very small molecular fragments and growing, merging, or linking them to produce drug leads. Because the affinities of the initial fragments are often low, detection methods are pushed to their limits, leading to a variety of artifacts, false positives, and false negatives that too often go unrecognized. This Digest discusses some of these problems and offers suggestions to avoid them. Although the primary focus is on FBLD, many of the lessons also apply to more established approaches such as high-throughput screening.
Language: English
Subfield: Drug Discovery
Open Access status: hybrid
Estimated APC paid: $3,880
OpenAlex ID: W2030316086
FWCI: 11.65
Cites: 77
Cited by: 164
Related to: 10